Zastosowanie propranololu w leczeniu naczyniaków dziecięcych

Infantile hemangiomas are the most common benign tumours in children. Although most hemangiomas can regress spontaneously in early childhood, some of them require treatment due to ulceration, bleeding, aesthetic deformity or impaired functions such as breathing or vision. Propranolol, a nonselective β-blocker, is currently first line therapy for treatment of head and neck hemangiomas that cause functional defects or significant disfigurement. The exact mechanism of propranolol action in hemangiomas treatment remains unclear. This paper presents review of current knowledge on propranolol in the treatment of infantile hemangiomas.